Search Login Register

Congenital Structural Myopathies (Centronuclear Myopathy) Summary

Description: A heterogeneous group of diseases characterized by the early onset of hypotonia, developmental delay of motor skills, non-progressive weakness. Each of these disorders is associated with a specific histologic muscle fiber abnormality.

Also Known As: Centronuclear Myopathy; Myotubular Myopathy; Myopathy, Myotubular; Myopathy, Centronuclear; Congenital Fiber Type Disproportion Show All >>

Networked: 173 relevant articles (2 outcomes, 7 trials/studies) for this Disease

Key Drugs and Agents for Congenital Structural Myopathies

Efficacy Chart >>
Drugs and Important Biological Agents (IBA) related to treatments:
  1. Dynamin II : 1 outcome 1 study in 46 results : IBA
  2. myotubularin : 1 outcome 1 study in 32 results : IBA
  3. Dynamins (Dynamin) : 1 study in 10 results : IBA
  4. Desmin : 1 study in 10 results : IBA
  5. Ryanodine Receptor Calcium Release Channel (Ryanodine Receptor) : 1 study in 7 results : IBA
  6. phosphatidylinositol 3-phosphate : 1 study in 7 results : IBA
  7. GTP Phosphohydrolases (GTPases) : 1 study in 6 results : IBA
  8. Vimentin : 1 study in 4 results : IBA
  9. DNA (Deoxyribonucleic Acid) : 1 study in 3 results : IBA
  10. Cytoskeletal Proteins : 1 study in 3 results : IBA
Show All >>

Diseases Related to Congenital Structural Myopathies

  1. Central Core Myopathy (Central Core Disease)
  2. Muscular Diseases (Myopathy)
  3. Congenital Structural Myopathies (Centronuclear Myopathy)
  4. Charcot-Marie-Tooth Disease (Peroneal Muscular Atrophy)
  5. Nemaline Myopathies (Nemaline Myopathy)
Show All >>

Key Therapies for Congenital Structural Myopathies

Efficacy Chart >>
  1. Orthognathic Surgery : 1 result
  2. Catheters : 1 result
  3. Transplants (Transplant) : 1 result
  4. Fundoplication : 1 result
  5. Heart Transplantation (Grafting, Heart) : 1 result
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.